Education
About Us
Working with TipRanks
Follow Us
Fusion Antibodies Plc (GB:FAB)
:FAB
RESEARCH TOOLSreports
FAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range2.80p - 12.00p
Previous CloseN/A
Volume21.95K
Average Volume (3M)840.60K
Market Cap
£7.71M
Enterprise Value3.60M
Total Cash (Recent Filing)£1.20M
Total Debt (Recent Filing)£43.00K
Price to Earnings (P/E)―
Beta-0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding113,318,140
10 Day Avg. Volume548,016
30 Day Avg. Volume840,596
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.71
Price to Cash Flow (P/CF)-4.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Fusion Antibodies Plc News
PremiumCompany Announcements
Fusion Antibodies Secures Grant for Cancer Treatment Development
PremiumCompany Announcements
Fusion Antibodies PLC Announces Major Shareholding Change
PremiumCompany Announcements
Fusion Antibodies Plc Announces Change in Voting Rights
PremiumCompany Announcements
Fusion Antibodies Raises £1.17 Million Following Successful General Meeting
PremiumCompany Announcements
Fusion Antibodies Announces Share Capital Details and Strategic Growth Focus
PremiumCompany Announcements
Fusion Antibodies Secures £1.17 Million in Conditional Share PlacingPremiumCompany Announcements
Fusion Antibodies Secures New Cell Line Development Contract
PremiumCompany Announcements
Fusion Antibodies Advances OptiMAL® Project with NCI Collaboration---
Options Prices
Currently, No data available
---
Ownership Overview
5.36% Insiders
―
Mutual Funds
― Other Institutional Investors
94.64% Public Companies and
Individual Investors
FAB FAQ
What was Fusion Antibodies Plc’s price range in the past 12 months?
Fusion Antibodies Plc lowest share price was 2.80p and its highest was 12.00p in the past 12 months.
What is Fusion Antibodies Plc’s market cap?
Fusion Antibodies Plc’s market cap is £7.71M.
When is Fusion Antibodies Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Fusion Antibodies Plc’s earnings last quarter?
Fusion Antibodies Plc released its earnings results on Sep 05, 2024. The company reported -0.011p earnings per share for the quarter, missing the consensus estimate of N/A by -0.011p.
Is Fusion Antibodies Plc overvalued?
According to Wall Street analysts Fusion Antibodies Plc’s price is currently Overvalued.
Does Fusion Antibodies Plc pay dividends?
Fusion Antibodies Plc does not currently pay dividends.
What is Fusion Antibodies Plc’s EPS estimate?
Fusion Antibodies Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fusion Antibodies Plc have?
Fusion Antibodies Plc has 113,318,140 shares outstanding.
What happened to Fusion Antibodies Plc’s price movement after its last earnings report?
Fusion Antibodies Plc reported an EPS of -0.011p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.13%.
Which hedge fund is a major shareholder of Fusion Antibodies Plc?
Currently, no hedge funds are holding shares in GB:FAB
---
Company Description
Fusion Antibodies Plc
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
---
Technical Analysis
RUA Life Sciences
―
Futura Medical
―
Oxford BioDynamics
―
Sareum Holdings
―
Scancell Holdings
―
---